The Center for Cancer Policy and Program Evaluation (CarPE) within the Department of Population Medicine serves as a catalyst for rigorous and impactful policy research across the cancer care spectrum by faculty in the DPM and our external collaborators. Our mission is to generate sound evidence to inform policies and programs along the cancer care continuum for use by domestic and international stakeholders, by leveraging the diverse research expertise in the DPM, effectively using and expanding our large existing data resources, and actively collaborating with partners of the DPM.
The DPM has been a long-standing home for population-level cancer research and was a founding member of the HMO Cancer Research Network and the Dana/Farber Harvard Cancer Center. Faculty research the cancer care continuum employing a range of quantitative and qualitative methods and come from across all DPM Divisions (CHeRP, HPI, CoRAL, TIDE/Sentinel, and Biostatistics). Common themes of our work include informing and evaluating health policies using large population-based electronic health data, in partnerships with payers and delivery systems.
DPM faculty study the short- and long-term effects of policies and interventions across the ever-evolving cancer screening and treatment environments. Current and future foci include:
- Immunization quality improvement programs to increase HPV vaccination in primary care
- Advances in screening technologies that can detect increasing numbers of cancers at early stages
- Rapid treatment advances coupled with faster FDA approval and increasing prices while questions about effectiveness and safety remain
- Legislation and contracting to facilitate access to cancer treatments
- Budgetary impacts of advances in screening and treatment on payers, employers, households, and society
- Ethical challenges for all stakeholders who need to weigh individual and societal benefits and risks